•
Jun 30, 2021

Align Q2 2021 Earnings Report

Announced record second quarter financial results and $1 billion in quarterly revenues for first time.

Key Takeaways

Align Technology reported a record second quarter with total revenues of $1.0 billion, up 186.9% year-over-year. Clear Aligner revenues were $841.0 million, up 181.9% year-over-year, and Imaging Systems and CAD/CAM Services revenues were $169.8 million, up 214.7% year-over-year. The company's diluted net income per share was $2.51, and non-GAAP diluted net income per share was $3.04.

Q2 total revenues up 13.0% sequentially and 186.9% year-over-year to a record $1.0 billion

Q2 diluted net income per share of $2.51; Q2 non-GAAP diluted net income per share of $3.04

Q2 operating margin of 26.6%, up 1.4 points sequentially and up 47.3 points year-over-year

Q2 Clear Aligner revenues up 11.6% sequentially and 181.9% year-over-year to a record $841.0 million

Total Revenue
$1.01B
Previous year: $352M
+187.0%
EPS
$3.04
Previous year: -$0.35
-968.6%
Invisalign Cases Shipped
665.6K
Previous year: 221.9K
+200.0%
Gross Profit
$759M
Previous year: $224M
+238.1%
Cash and Equivalents
$1.1B
Previous year: $404M
+172.0%
Free Cash Flow
$193M
Previous year: $25.5M
+658.4%
Total Assets
$5.4B
Previous year: $4.03B
+34.0%

Align

Align

Align Revenue by Segment

Forward Guidance

Align is increasing its 2021 revenue guidance provided in April on the Q1’21 earnings call to a range of $3.85 billion to $3.95 billion. Additionally, they now expect their second half year-over-year revenue growth rate to be above the mid-point of their long-term operating model target of 20% to 30%. On a GAAP basis, they now anticipate their 2021 operation margin to be better than their prior guidance, in the range of 24.0% and 25.0%. On a Non-GAAP basis, they expect the 2021 operating margin to be approximately 3 points higher than their GAAP operating margin, after excluding stock-based compensation and intangible amortization.

Positive Outlook

  • Net revenues in the range of $3.85 billion to $3.95 billion, up approximately 56% to 60% over full-year 2020.
  • Expect 2H year-over-year revenue growth to be above the mid-point of our long-term operating model target of 20% to 30%
  • GAAP operating margin in the range of 24.0% to 25.0%
  • Non-GAAP operating margin to be approximately 3 points higher than GAAP operating margin
  • During Q3'21 we expect to repurchase up to $75 million of our common stock through either or a combination of open market repurchases or an accelerated stock repurchase agreement

Challenges Ahead

  • There continues to be uncertainty around the pandemic and increasing restrictions related to COVID-19 in certain geographies
  • Anticipating more pronounced summer seasonality across all regions than we have experienced in recent years, as doctors, their staff, and patients take long overdue vacations.
  • Difficulties predicting customer and consumer purchasing behavior and changes in consumer spending habits as a result of prevailing economic conditions
  • Increasing competition from existing and new competitors
  • Foreign operational, political and other risks relating to our international manufacturing operations

Revenue & Expenses

Visualization of income flow from segment revenue to net income